• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻女性口服避孕药与癌性乳房的组织病理学。英国国家病例对照研究小组成员。

Oral contraceptive use and histopathology of cancerous breasts in young women. Members of the U.K. National Case-Control Study Group.

作者信息

Hulman G, Trowbridge P, Taylor C N, Chilvers C E, Sloane J P

机构信息

Department of Histopathology, Royal Marsden Hospital.

出版信息

J Pathol. 1992 Aug;167(4):407-11. doi: 10.1002/path.1711670410.

DOI:10.1002/path.1711670410
PMID:1403359
Abstract

A retrospective histopathological study of 300 women under 36 years of age was carried out to determine whether breast cancers occurring in oral contraceptive users showed any differences in pathological features compared with non-users. The patients belong to an age group in which an increased risk of cancer development has been reported following oral contraceptive usage. The incidence of non-neoplastic conditions in the residual breast was also studied in the two groups. There was little difference between breast cancers arising in pill users and non-users but in the residual non-neoplastic breast a decreased incidence of cysts and blunt duct adenosis was found in current users of the contraceptive pill. In contrast, lactational foci were found only in the breasts of pill users. The incidence of intraductal hyperplasia was not significantly different in the two groups.

摘要

对300名36岁以下女性进行了一项回顾性组织病理学研究,以确定口服避孕药使用者患乳腺癌的病理特征与非使用者相比是否存在差异。这些患者属于据报道口服避孕药使用后癌症发生风险增加的年龄组。还对两组残余乳腺中的非肿瘤性疾病发病率进行了研究。口服避孕药使用者和非使用者患乳腺癌的情况几乎没有差异,但在残余的非肿瘤性乳腺中,避孕药当前使用者的囊肿和钝性导管腺病发病率降低。相比之下,仅在口服避孕药使用者的乳房中发现了哺乳期病灶。两组导管内增生的发生率没有显著差异。

相似文献

1
Oral contraceptive use and histopathology of cancerous breasts in young women. Members of the U.K. National Case-Control Study Group.年轻女性口服避孕药与癌性乳房的组织病理学。英国国家病例对照研究小组成员。
J Pathol. 1992 Aug;167(4):407-11. doi: 10.1002/path.1711670410.
2
Weighing the evidence on the pill and breast cancer.权衡关于避孕药与乳腺癌的证据。
Fam Plann Perspect. 1989 Mar-Apr;21(2):89-92.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
4
Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia.
N Engl J Med. 1978 Aug 24;299(8):381-5. doi: 10.1056/NEJM197808242990803.
5
Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?性甾体激素与乳腺癌:与口服避孕药及激素替代疗法有关联吗?
Med J Aust. 1992 Jan 20;156(2):124-32.
6
Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.年轻女性乳腺癌中口服避孕药的使用及其他与HER-2/neu过表达相关的风险因素。
Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):413-9.
7
Oral contraception and breast pathology.口服避孕药与乳腺病理学。
Acta Eur Fertil. 1981 Jun;12(2):141-63.
8
Long-term health risks and benefits of oral contraceptive use.口服避孕药的长期健康风险与益处
Obstet Gynecol Clin North Am. 1990 Dec;17(4):775-88.
9
[Significance of proliferative breast lesions around breast cancers].[乳腺癌周围增殖性乳腺病变的意义]
Gan To Kagaku Ryoho. 1995 Apr;22 Suppl 1:42-5.
10
Comparing the health risks and benefits of contraceptive choices.比较避孕选择的健康风险与益处。
Fam Plann Perspect. 1991 Mar-Apr;23(2):54-61.